Sigma-Aldrich Moves to Fill a Gap in Molecular Biology Tools Product Line | GenomeWeb

When Sigma-Aldrich announced a licensing agreement with St. Louis-based InGex last week, the chemical giant was not only sealing a deal to add an entirely new product line into its molecular biology tools portfolio, and sell more oligonucleotides and reagents from its website, it was also also taking an option on a platform with the potential to spin off new products to meet future market demands.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.